Nephrotoxic Medications in This List
Among the medications listed, furosemide, losartan, and aspirin carry nephrotoxic risk, while the remaining medications are generally safe for the kidneys when used appropriately.
Medications with Nephrotoxic Potential
Furosemide (Loop Diuretic)
Furosemide can cause kidney dysfunction through multiple mechanisms 1:
- Volume depletion and hypoperfusion: Excessive diuresis reduces renal blood flow
- Electrolyte disturbances: Can precipitate acute kidney injury (AKI) through hypokalemia and metabolic alkalosis
- Enhanced nephrotoxicity of other drugs: Increases risk when combined with aminoglycosides, cisplatin, or cephalosporins 1
- Nephrocalcinosis: Particularly in premature infants, but relevant for chronic use 1
Critical interaction: When combined with losartan (an ARB), furosemide can lead to severe hypotension and deterioration in renal function, including renal failure 1. This combination requires careful monitoring, though it's commonly used clinically with appropriate oversight 2.
Losartan (Angiotensin Receptor Blocker)
Losartan affects kidney function through hemodynamic mechanisms 3, 4:
- Expected creatinine rise: Up to 30% increase in serum creatinine is physiological and acceptable 5
- Risk of acute renal failure: In patients with severe bilateral renal artery stenosis 4
- Hyperkalemia risk: Especially in chronic kidney disease (CKD) or when combined with potassium supplements 4
Important caveat: Despite causing functional creatinine increases, ARBs are actually renoprotective long-term and should not be discontinued for modest, stable creatinine elevations up to 30% 5, 6, 7. The benefits on mortality and slowed CKD progression outweigh the hemodynamic effects 5.
Aspirin (Low-dose)
At 81 mg daily, aspirin carries minimal nephrotoxic risk 2:
- Rare tubulo-interstitial nephritis: Idiosyncratic reaction, very uncommon at low doses
- Risk increases: When combined with other NSAIDs 2
- Functional effects: High doses can affect renal prostaglandins, but 81 mg is generally safe
One study showed: The combination of furosemide and aspirin temporarily reduced creatinine clearance in patients with chronic renal insufficiency 1, though this is not typically clinically significant at low aspirin doses.
Medications WITHOUT Direct Nephrotoxic Effects
The following medications are not nephrotoxic when used at prescribed doses:
- Albuterol inhaler: No renal toxicity
- Atorvastatin: Safe in kidney disease; no nephrotoxicity
- Bupropion: Hepatically metabolized; not nephrotoxic (requires dose adjustment in severe renal impairment but doesn't cause kidney damage) 8
- Carvedilol: Safe; may actually have renoprotective effects through sympathetic inactivation 2
- Citalopram: No nephrotoxicity
- Vitamin D2: Safe; no renal toxicity
- Glipizide: Not nephrotoxic (though requires monitoring in renal impairment for hypoglycemia risk) 9
- Levothyroxine: No nephrotoxicity
- Tirzepatide: Not nephrotoxic; actually shows cardiovascular and metabolic benefits 10
- Pregabalin: Renally cleared but not nephrotoxic; requires dose adjustment in renal impairment
- Insulin glargine: No nephrotoxicity
Clinical Management Recommendations
For the furosemide-losartan combination 1:
- Monitor serum creatinine and electrolytes regularly 11
- Accept up to 30% creatinine increase with losartan if stable 5, 6
- Watch for volume depletion signs
- Reduce or interrupt furosemide if creatinine rises >30% or continues worsening 6
- Monitor potassium closely (losartan retains potassium, furosemide wastes it)
Key monitoring parameters 11:
- Baseline and periodic eGFR and electrolytes
- More frequent monitoring during dose adjustments
- Assess volume status clinically
Common pitfall: Discontinuing losartan for minor creatinine elevations (<30%) is an error that removes renoprotective benefit 5, 6. The maximally tolerated ARB dose provides the greatest long-term kidney protection.